Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123306) titled 'A Randomized Controlled Trial of OOSP2 Protein on Improving Oocyte In Vitro Fertilization and Early Embryonic Development in Patients of Advanced Maternal Age' on April 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Reproductive Medicine Center of the Sixth Affiliated Hospital of Sun Yan-Sen University
Condition:
infertility
Intervention:
OOSP2 group:Fertilization medium and embryo culture medium supplemented with recombinant OOSP2 protein.
Recruitment Status: Recruiting
Phase: New Treatment Measure Clinical Study
Date of First Enrollment: 2025-11-19
Target Sample Size: O...